Safe Human iPSC for your Therapy and Research

iPSCs (Induced Pluripotent Stem Cells) serve as a “raw material” for therapy and research since they induce various organ-specific cells or tissues (retina, liver, heart, kidney, etc.).These cells play a vital role in future regenerative medicine, enabling disease modelling, drug discovery, testing and repurposing. Join Cellagility Biomed on a journey to derive, evaluate, store and supply iPSCs playing a role in driving economic growth servicing a new healthcare vision making stem cell treatments more accessible.

Founded 2018, building a GMP lab in collaboration with the Bangalore Bio-innovation Centre, the founders combine Indian skills with Japanese scientific know-how and British quality assurance. A growing team is on schedule to complete facility verification and a proof of concept (POC). This will confirm our capability in Bengaluru to supply safe, viable and affordable iPSC lines, opening a source for bench-marked and ethically derived cells of international appeal.